Announcement on the Sale of Equity of Shouhang Jieneng (Quanzhou) Medical Technology Co., Ltd., a wholly-owned Sun Company
Time:2020-06-19
Classification: Company Announcement
I. Transactions
1. In February 2020, at the call of the local government, in order to alleviate the shortage of mask supply, Shouhang High-tech Energy Technology Co., Ltd. (hereinafter referred to as "the company" or "Shouhang High-tech") successively established Shouhang Clean Energy (Quanzhou) Medical Technology Co., Ltd. (hereinafter referred to as "the target company") and Tianjin Shouhang Clean Energy Technology Co., Ltd, the two companies mainly produce masks.
At present, the mask industry has entered the buyer's market, serious overcapacity, a large number of small and medium-sized mask enterprises have stopped production or production reduction, small and medium-sized mask enterprises production and operation is more difficult. However, the two mask companies of Shouhang Hi-Tech also have certain advantages, such as relatively standardized production environment, perfect quality inspection system, and relatively complete qualifications.
In order to reduce personnel expenses, reduce factory rent, reduce personnel travel expenses, marketing expenses and other expenses, and make full use of the company's existing production base and personnel in Tianjin, Shouhang Hi-Tech decided to adjust the mask production layout, centralize the mask production and operation to Tianjin Shouhang Jieneng Technology Co., Ltd., and sell the controlling stake in Shouhang Jieneng (Quanzhou) Medical Technology Co., Ltd.
2. After negotiation, Shouhang Jieneng Technology Co., Ltd. sold 90% of the equity of Shouhang Jieneng (Quanzhou) Medical Technology Co., Ltd. to Quanzhou Hualian IOT Technology Co., Ltd. at the price of 34 million yuan.
3. The fourth meeting of the company's fourth board of directors reviewed and approved the "Proposal on the Sale of Equity in Shouhang Jieneng (Quanzhou) Medical Technology Co., Ltd.", which was approved by 9 votes, 0 votes against, and abstention. 0 votes.
4. The equity transfer of this wholly-owned Sun Company is within the decision-making authority of the company's board of directors and does not need to be submitted to the general meeting of shareholders for consideration and approval. 5. The equity transfer of this wholly-owned Sun Company does not constitute a connected transaction. Nor does it constitute a major asset reorganization as stipulated in the Measures for the Administration of Major Asset Reorganization of Listed Companies.
Basic information about 2. counterparties
1. Company Name: Quanzhou Hualian IOT Technology Co., Ltd.
2. Registration number: 91350583MA33FGCG80
3. Registered capital: 10 million yuan
Legal Representative: Yi Yongquan
5. Domicile: No. 109-3, Nanmei Road, Meilin Street, Nanan City, Quanzhou City, Fujian Province
6. Company type: limited liability company (wholly owned by natural person)
7. Business scope: Internet of Things technology development; industrial robots, logistics and warehousing automation system equipment, automated assembly and testing production lines and system integration, traffic automation systems and other related products research and development, design, manufacturing and sales.
8. As of the date of disclosure, Quanzhou Hualian IOT Technology Co., Ltd. does not have any relationship with the top ten shareholders of the Company in terms of property rights, business, assets, creditor's rights and debts, personnel, etc., nor does it have any other relationship that may or has caused the Company to tilt its interests.
III. Basic information on the subject matter of the transaction
1. Company Name: Shouhang Jieneng (Quanzhou) Medical Technology Co., Ltd.
2. Registration number: 91350583MA33JPK04L
3. Registered capital: 30 million yuan
4. Legal Representative: Huang Qingle
5. Domicile: Zhuyuan Village, Merrill Lynch Maosheng Road, Nanan City, Quanzhou City, Fujian Province
6. Company type: limited liability company (natural person investment or holding)
7. Business scope: medical technology research and development; production and sales: Class II and III 6864 medical sanitary materials, auxiliary materials and their products, medical clothing, textiles, non-woven products and molded packaging (the above products do not include national export license management products) And related products disposable consumables and molded packaging; production and sales: non-medical daily protective masks, labor protection products, personal protective equipment; engaged in Class I medical devices, Class II medical devices (excluding in vitro diagnostic reagents), III medical devices, medical sanitary materials and auxiliary materials, medical suture materials and adhesives, medical polymer materials and products (except disposable infusion (blood) devices (needles)), general diagnostic equipment, medical cold therapy, low temperature, refrigeration equipment and appliances, cotton household products, cotton clothing, cotton clothing, cotton spunlace wholesale of non-woven fabrics and their products, cotton, disinfection products (excluding dangerous chemicals), labor protection masks and daily necessities; import and export of goods or technologies (except for goods and technologies prohibited by the state or involving administrative approval); provide technical consultation, technical services and after-sales services for the above-mentioned products; sterilization technical services (if relevant qualifications are required to operate, apply in accordance with relevant regulations); enterprise management consulting, business information consulting, economic information consulting (excluding financial, securities, futures and other consulting projects that require permission); warehousing services (excluding dangerous chemicals, precursor chemicals, refined oil and other dangerous goods); lease of self-owned real estate (operated only with the legal real estate certificate under the company's name); property management. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)
8. Shareholder structure of the subject company before the sale:
| Name of Shareholder | Registered capital (ten thousand yuan) | Actual contribution (ten thousand yuan) | Shareholding ratio |
| Shouhang Clean Energy Technology Co., Ltd. | 3,000 | 3,000 | 100% |
9. Main financial data:
Unit: ten thousand yuan
| Main financial indicators | May 31, 2020 (unaudited) |
| Total assets | 5,195.72 |
| Total Liabilities | 1,420.52 |
| Net assets | 3,775.20 |
| Main financial indicators | February-May 2019 (unaudited) |
| Operating income | 1,879.99 |
| Operating costs | 938.75 |
| Net profit | 775.19 |
10. Other description of the subject matter of the transaction
The subject of this transaction is 90% of the equity of the subject company held by Shouhang Clean Energy Technology Co., Ltd., with clear property rights, no mortgage, pledge or any other restrictions on transfer, no litigation, arbitration matters or judicial measures such as seizure or freezing, and no other circumstances that hinder the transfer of ownership. The sale of shares will result in a change in the scope of the Company's consolidated financial statements, and the subject company will no longer be included in the scope of the Company's consolidated financial statements upon completion of the transaction. The Company and Shouhang Clean Energy Technology Co., Ltd. do not provide guarantees for the subject company or entrust the subject company with financial management.
IV. Main Contents of the Agreement
(I) Parties to the Agreement
Seller: Shouhang Clean Energy Technology Co., Ltd.
Buyer: Quanzhou Hualian Technology Co., Ltd.
(ii) Subject matter of the transaction
The seller holds 90% equity interest in Shouhang Jiereng (Quanzhou) Medical Technology Co., Ltd.
(3) Equity transfer price The transfer price is RMB 34 million yuan. The equity transaction payment of RMB 10 million yuan shall be paid within 10 working days after the signing of this agreement, and then the equity change registration shall be handled. The remaining 24 million yuan equity transaction payment shall be paid within 20 working days after the completion of the equity change registration. If the buyer fails to pay the full amount of the equity transaction within 60 days after the completion of the equity change, the seller shall have the right to recover the equity and deduct 10 million yuan as compensation.
(iv) Entry into force of the agreement
The agreement shall enter into force after it is signed and sealed by the parties.
Pricing basis for 5. transaction
The pricing of the transaction was determined through negotiation between the buyer and the seller and is based on the net assets of the subject company. The pricing of this transaction is in line with the principles of objectivity and fairness, equality and voluntariness, and the price is fair, and there is no situation that harms the interests of the majority of small and medium investors.
VI. Other arrangements for the transaction
The transaction does not involve the transfer of credit and debts, personnel placement or land lease, or changes in senior personnel of the Company. This transaction does not constitute a related transaction, and there is no competition with related parties after the completion of the transaction.
7. the impact of this transaction
The transaction is conducive to further integrating the Company's existing mask production resources, reducing costs and enhancing economies of scale, which is in line with the Company's actual operation and future development needs. The sale of shares will result in a change in the scope of the Company's consolidated financial statements, and the subject company will no longer be included in the scope of the Company's consolidated financial statements upon completion of the transaction. After the completion of the transaction, the company will mainly develop the mask and related business of Tianjin Shouhang Clean Energy Technology Co., Ltd.
8. Documents for Reference
1. Resolutions of the fourth meeting of the fourth board of directors of the company;
2. Equity Transfer Agreement.
It is hereby announced.
Shouhang Gaoke Energy Technology Co., Ltd.
Board of Directors
June 18, 2020